Considering the pivotal role of natural products in unleashing the therapeutic potential of PXR as a drug target, particularly in the context of metabolic diseases, traditional Chinese medicines (TCMs) may hold unique promise for future drug discovery endeavors. The gene discussed is NR1I2; the disease is Other metabolic disease.